期刊文献+

慢性B淋巴细胞白血病CD4^+CD25^+highCD127^Low和CD19^+-CD23^+的相关性研究 被引量:1

Correlation of CD4^+CD25^+highCD127^Low with CD19^+CD23^+ in patients with chronic B cell lymphocytic leukemia
下载PDF
导出
摘要 目的通过研究慢性B淋巴细胞白血病(chronic B cell lymphocytic leukemia,B—CLL)CD4^+CD25^+highCDl27^Low和CD19^+CD23^+的相关性,探讨CD4^+CD25^+highCDl27^Low在B—CLL发生发展过程中的作用。方法将20例初次发病的B—CLL患者按临床分期的不同分为O-II期组、III-IV期组,设立正常对照组,应用流式细胞仪检测各组的研究对象外周血中CD4^+CD25^+highCDl27^Low、CD19^+、CD19^+CD23^+的表达量,比较各组间的差异。结果B—CLL O-II期组、III-IV期组患者外周血中CD4^+CD25^+highCDl27^Low、CD19^+、CD19^+CD23^+的表达量均明显高于正常对照组;B—CLL患者III-IV期组的CD4^+CD25^+highCDl27^Low、CDl9^+、CDl9^+CD23^+表达量明显高于O-II期组;CD4^+CD25^+highCDl27^Low、CDl9^+CD23^+有明显的正相关性。结论B—CLL患者外周血中CD4^+CD25^+highCD127^Low的表达量增高,与CD19^+、CD19^+CD23^+的表达量增高明显相关,可能是B—CLL患者CD19^+CD23^+克隆性增生原因之一. Objective To investigate the correlation of CD4^+CD25^+highCDl27^Low with CD19^+CD23^+ in patients with chronic B cell lymphocytic leukemia (B-CLL). Methods Twenty cases of B-CLL were classified as phase O-II group and phase Ill-IV group. CD4^+CD25^+highCDl27^Low, CD19^+, CD19^+CD23^+ were analyzed by flow cytometry. Results CD4^+CD25^+highCDl27^Low, CD19^+ and CD19^+CD23^+ in B-CLL patients were significantly higher than those of normal controls; and the above markers in phase Ill-IV group were significantly higher than those in phase O-II group. There was a positive correlation of CD4^+CD25^+highCDl27^Low with CD19^+ and CD19^+CD23^+. Conclusion CD4^+CD25^+highCDl27^Low is highly expressed in B-CLL and is positively correlated with CD19^+ and CD19^+/CD23^+,which may be a main cause of CD19^+CD23^+-cloning hyperplasia in B-CLL .
出处 《浙江医学》 CAS 2010年第8期1193-1195,共3页 Zhejiang Medical Journal
基金 浙江省医药卫生科学研究基金项目计划(编号:2010KYA015)
关键词 慢性B淋巴细胞白血病 CD4^+CD25^+highCD127^Low CD19^+/CD23^+ 流式细胞术 B-chronic lymphocytic leukemia CD4^+CD25^+highCDl27^Low CD19^+CD23^+ Flow cytometry
  • 相关文献

参考文献13

  • 1Sakaguch S,Noriko Sakaguch,Jun Shimizu,et al.Immunologic tolerance maintained by CD25+CD4+ regulatory T cells:their common role in controlling autoimmunity,tumor immunity,and transplantation tolerance[J].Immunol Rev,2001,182(1):18-32.
  • 2Wolf AM,Wolf D,Steurer M,et al.Increase in regulatory T cells in the peripheral blood of cancer patients[J].Clin Cancer Res,2003,9(2):606-612.
  • 3Schaefer C,kim G,Albers A,et al.Characteristics of CD4+CD25+regulatory T cell in the peripheral circulations of patients with head and neck cancer[J].Br J Cancer,2005,92(5):913-920.
  • 4Liyange UK,Moore TT,Joo HG,et al.Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma[J].Immunology,2002,169(5):2756-2761.
  • 5Sasada T,Kimuia,Yoshida Y,et al.CD4^+CD25^+ regulatory T cells in patients with gastrointestinal malignancies:Possible involvement of regulatory T cells in disease progression[J].Cancer,2003,98(5):1089-1099.
  • 6Armltage ILI,Gof LK.Functional interaction between B cell Subpopulations defined by CD23 expression[J].Eur J hnmunol,1998.18(11):1753-1760.
  • 7Higeko Kijimoto-Ochiai,Atsutaka Noguchi,Toshiyuki Ohnishi.Complex formation of CD23/surface immunoglobulin and CD23/CD81/MHC class Ⅱ on an EBV-transformed human B cell line and inferable role of tetraspanin[J].Microbiol Immunol,2004,48(5):417-426.
  • 8Costantino CM,Baecher-Allan CM,Hafler DA.Human regulatory T cells and autoimmunity[J].Eur Immunol,2008,38(4):921-924.
  • 9Fontenot JD,Rudensky AY.A well adapted regulatory contrivance:regulatory T cell development and the forkhead family transcription factor Foxp3[J].Nat Immunol,2005,6(4):331-337.
  • 10Liu WH,Putnam AL,Zhou XY,et al.CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4^+ Treg cells[J].J Exp Med,2006,203(7):1701-1711.

同被引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部